Stay updated on INTEGA: Ipilimumab & FOLFOX + Nivolumab & Trastuzumab Clinical Trial
Sign up to get notified when there's something new on the INTEGA: Ipilimumab & FOLFOX + Nivolumab & Trastuzumab Clinical Trial page.

Latest updates to the INTEGA: Ipilimumab & FOLFOX + Nivolumab & Trastuzumab Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedAdded the disease tag Gastric cancer and a Resources link to the Genetic and Rare Diseases Information Center. Updated page revision from v3.4.1 to v3.4.2.SummaryDifference0.2%

- Check18 days agoChange DetectedRevision: v3.4.1 replaces v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check32 days agoChange DetectedMinor UI text and label changes were made, including the addition of glossary toggle options and small wording/case updates (e.g., 'Last Update Submitted that Met QC Criteria', 'No FEAR Act Data', and 'Revision: v3.4.0'). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check40 days agoChange DetectedRevision: v3.3.4 was added and Revision: v3.3.3 was removed; this update does not change the study content, eligibility criteria, or locations. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check69 days agoChange DetectedFooter now includes Revision: v3.3.3; the HHS Vulnerability Disclosure and Revision: v3.3.2 items were removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check91 days agoChange DetectedPublications description updated to 'These publications are automatically filled in from PubMed, a public database of scientific and medical articles, and may or may not be about the study,' and the page revision label changed from v3.2.0 to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to INTEGA: Ipilimumab & FOLFOX + Nivolumab & Trastuzumab Clinical Trial
Enter your email address, and we'll notify you when there's something new on the INTEGA: Ipilimumab & FOLFOX + Nivolumab & Trastuzumab Clinical Trial page.